about
Bevacizumab versus ranibizumab for neovascular age-related macular degeneration: a Meta-analysis.Comparison of bevacizumab and ranibizumab in age-related macular degeneration: a systematic review and meta-analysis.Aflibercept, bevacizumab, or ranibizumab for diabetic macular edemaIntravitreal ranibizumab as a primary or a combined treatment for severe retinopathy of prematuritySite-Specific Labeling of scVEGF with Fluorine-18 for Positron Emission Tomography ImagingSuggestive association between PLA2G12A single nucleotide polymorphism rs2285714 and response to anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration.Efficacy of intravitreal ranibizumab injection in acute nonarteritic ischemic optic neuropathy: a long-term follow up.Understanding of dopant-induced osteogenesis and angiogenesis in calcium phosphate ceramicsAntiangiogenic agents in natural products for the treatment of gynecologic disorders.Current and investigational pharmacotherapeutic approaches for modulating retinal angiogenesis.Inhibition of proliferation of retinal vascular endothelial cells more effectively than choroidal vascular endothelial cell proliferation by bevacizumab.Protective Effects of Human iPS-Derived Retinal Pigmented Epithelial Cells in Comparison with Human Mesenchymal Stromal Cells and Human Neural Stem Cells on the Degenerating Retina in rd1 mice.
P2860
Q35075402-2ABCA908-D784-4D78-B5F7-81930B7EEB9AQ35162123-2BD16523-67F1-4C10-A6AF-3203A378C88DQ35575496-0340C6BC-4454-4266-855C-9A313B84EF13Q35851949-F4DC6FEE-2445-4482-A633-3FBA1A8C4701Q36072875-912DAECC-7629-450F-BEEC-4431FABBF9A3Q36350410-E96A3879-EEED-4A35-B380-D8C27A14E56CQ37226587-8B0B1FF2-ECBA-45B8-80A6-062EC9D8F5E5Q37301792-3CC4C62F-8112-47B9-8915-B8B703A1A339Q38177316-6B40B9CA-F884-48CE-8257-472512F39F92Q38192060-89E2F032-5444-4429-8A64-B41B561B4D2CQ41191124-021F175F-113D-40A0-9FDD-941516F84FF7Q50598351-063C20D7-6416-4AD6-88CD-30577559F0E8
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Lasting controversy on ranibizumab and bevacizumab.
@ast
Lasting controversy on ranibizumab and bevacizumab.
@en
type
label
Lasting controversy on ranibizumab and bevacizumab.
@ast
Lasting controversy on ranibizumab and bevacizumab.
@en
prefLabel
Lasting controversy on ranibizumab and bevacizumab.
@ast
Lasting controversy on ranibizumab and bevacizumab.
@en
P2093
P2860
P356
P1433
P1476
Lasting controversy on ranibizumab and bevacizumab.
@en
P2093
P2860
P304
P356
10.7150/THNO/V01P0395
P577
2011-12-12T00:00:00Z